In the competitive landscape of pharmaceutical manufacturing, the efficiency and success of API synthesis are directly tied to the quality and reliability of the raw materials and intermediates used. For the production of Gefitinib, a crucial targeted therapy for certain cancers, the intermediate N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (CAS 179552-74-0) plays a critical role. The choice of supplier for this compound is therefore a strategic decision that can significantly impact production timelines, costs, and the final product's quality.

As a premier manufacturer and supplier of pharmaceutical intermediates, we understand the intricacies of Gefitinib synthesis. Our N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine is produced with a meticulous focus on purity (≥98.0%) and consistency, ensuring it performs optimally in downstream reactions. Sourcing this intermediate from a reputable China-based manufacturer like ourselves provides several advantages: consistent quality control, competitive pricing, and a robust supply chain designed to meet the demands of pharmaceutical production. We aim to be more than just a supplier; we strive to be a trusted partner who contributes to the seamless execution of your synthesis projects.

The physical and chemical properties of N-(3-chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine, such as its defined molecular weight and appearance as a yellow powder, are thoroughly documented and maintained. This meticulous approach allows our clients to confidently integrate our intermediate into their established processes. When you need to buy this essential component for Gefitinib manufacturing, consider the long-term benefits of partnering with a supplier that prioritizes quality and reliability. We are equipped to support your research and large-scale production needs, offering exceptional value and dependable service. Contact us to learn how our high-quality intermediate can optimize your Gefitinib synthesis.